{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:27:40Z","timestamp":1771298860102,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2022\/1225542-0"],"award-info":[{"award-number":["2022\/1225542-0"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Rheumatic heart disease, the long-term sequel to acute rheumatic fever, remains a prevalent public health problem in Africa and other low to middle-income regions of the world. Diagnosing acute rheumatic fever and using the modified Jones criteria in high-prevalence areas remains challenging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We assessed the (i) diagnostic accuracy of simplified diagnostic algorithms among children, adolescents, and adults with suspected acute rheumatic fever, and (ii) the impact of different diagnostic criteria on the development of rheumatic heart disease (PROSPERO CRD42022344077). The MEDLINE, Embase, and Conference Proceedings Citation Index-Science were searched for relevant reports (date: 15th March 2025).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Here we identify 12,075 records, and three studies (four reports) meeting our eligibility criteria. Simplified diagnostic algorithms using only clinical data at community health centre-level (AUC 0.69, sensitivity 66% and specificity 68%), or adding 12-lead electrocardiogram and simple laboratory investigations at district-level facilities (AUC 0.76, sensitivity 77% and specificity 67%) perform worse than models including the full-set of laboratory investigations and echocardiography at National referral hospitals (AUC 0.91, sensitivity 84% &amp; specificity 87%). Using modified Jones criteria without echocardiography results in an important loss of sensitivity (sensitivity 79%, specificity 100% &amp; AUC 0.90). Progression to rheumatic heart disease is reported in 2.5\u20135% of children and young adults in high-prevalence areas who do not meet the full modified Jones criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Simplification of the modified Jones criteria in areas without access to echocardiography and laboratory investigations may lead to underdiagnosis of acute rheumatic fever. Some patients who do not meet the modified Jones criteria for definite acute rheumatic fever diagnosis may still progress to develop rheumatic heart disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-01023-1","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:12:29Z","timestamp":1754979149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic test accuracy of simplified algorithms for diagnosing acute rheumatic fever: a systematic review"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-9883","authenticated-orcid":false,"given":"Rui","family":"Providencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Aali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6676-1270","authenticated-orcid":false,"given":"Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Katairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan JH","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Pelone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloi","family":"Marijon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miryan","family":"Cassandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Celermajer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Shokraneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1023_CR1","first-page":"CD002227","volume":"2002","author":"J Manyemba","year":"2002","unstructured":"Manyemba, J. & Mayosi, B. M. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. 2002, CD002227 (2002).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1023_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41569-023-00940-9","volume":"21","author":"B Rwebembera","year":"2024","unstructured":"Rwebembera, B. et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat. Rev. Cardiol. 21, 250\u2013263 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1023_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1542\/pir.2019-0288","volume":"42","author":"S Lahiri","year":"2021","unstructured":"Lahiri, S. & Sanyahumbi, A. Acute rheumatic fever. Pediatr. Rev. 42, 221\u2013232 (2021).","journal-title":"Pediatr. Rev."},{"key":"1023_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins, D. A. et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N. Engl. J. Med. 377, 713\u2013722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1023_CR5","unstructured":"World Health Organization. Rheumatic fever and rheumatic heart disease. Seventy-first world health assembly: Provisional Agenda Item 12.8 [Available from: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA71\/A71_25-en.pdf] (2018)."},{"key":"1023_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jama.1944.02850430015005","volume":"126","author":"TD Jones","year":"1944","unstructured":"Jones, T. D. The diagnosis of rheumatic fever. JAMA 126, 481\u2013484 (1944).","journal-title":"JAMA"},{"key":"1023_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0167-5273(86)90264-0","volume":"12","author":"S Bhattacharya","year":"1986","unstructured":"Bhattacharya, S. & Tandon, R. The diagnosis of rheumatic fever-evolution of the Jones criteria. Int. J. Cardiol. 12, 285\u2013294 (1986).","journal-title":"Int. J. Cardiol."},{"key":"1023_CR8","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","volume":"131","author":"MH Gewitz","year":"2015","unstructured":"Gewitz, M. H. et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 131, 1806\u20131818 (2015).","journal-title":"Circulation"},{"key":"1023_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/heartasia-2015-010648","volume":"7","author":"A Beaton","year":"2015","unstructured":"Beaton, A. & Carapetis, J. The 2015 revision of the Jones criteria for the diagnosis of acute rheumatic fever: implications for practice in low-income and middle-income countries. Heart Asia 7, 7\u201311 (2015).","journal-title":"Heart Asia"},{"key":"1023_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jsha.2019.07.002","volume":"31","author":"J Alqanatish","year":"2019","unstructured":"Alqanatish, J., Alfadhel, A., Albelali, A. & Alqahtani, D. Acute rheumatic fever diagnosis and management: Review of the global implications of the new revised diagnostic criteria with a focus on Saudi Arabia. J. Saudi Heart Assoc. 31, 273\u2013281 (2019).","journal-title":"J. Saudi Heart Assoc."},{"key":"1023_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685\u2013694 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"1023_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/jpc.15664","volume":"57","author":"J Bennett","year":"2021","unstructured":"Bennett, J. et al. Early diagnosis of acute rheumatic fever and rheumatic heart disease as part of a secondary prevention strategy: Narrative review. J. Paediatr. Child Health 57, 1385\u20131390 (2021).","journal-title":"J. Paediatr. Child Health"},{"key":"1023_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00257-5","volume":"8","author":"C Tian","year":"2017","unstructured":"Tian, C. et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat. Commun. 8, 599 (2017).","journal-title":"Nat. Commun."},{"key":"1023_CR14","doi-asserted-by":"publisher","first-page":"e25326","DOI":"10.1371\/journal.pone.0025326","volume":"6","author":"ME Engel","year":"2011","unstructured":"Engel, M. E., Stander, R., Vogel, J., Adeyemo, A. A. & Mayosi, B. M. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS ONE 6, e25326 (2011).","journal-title":"PLoS ONE"},{"key":"1023_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0974-2069.79617","volume":"4","author":"L Guilherme","year":"2011","unstructured":"Guilherme, L., Kohler, K. F., Postol, E. & Kalil, J. Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann. Pediatr. Cardiol. 4, 13\u201321 (2011).","journal-title":"Ann. Pediatr. Cardiol."},{"key":"1023_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/20469047.2019.1682330","volume":"40","author":"S Epcacan","year":"2020","unstructured":"Epcacan, S. & Yucel, E. Serum periostin levels in acute rheumatic fever: is it useful as a new biomarker?. Paediatr. Int. Child Health 40, 111\u2013116 (2020).","journal-title":"Paediatr. Int. Child Health"},{"key":"1023_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/tropej\/fmt058","volume":"59","author":"Z Karatas","year":"2013","unstructured":"Karatas, Z., Baysal, T., Alp, H. & Toker, A. Serum tenascin-C: a novel biomarker for diagnosis and predicting prognosis of rheumatic carditis?. J. Trop. Pediatr. 59, 476\u2013482 (2013).","journal-title":"J. Trop. Pediatr."},{"key":"1023_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/BPO.0000000000000261","volume":"35","author":"RM Mistry","year":"2015","unstructured":"Mistry, R. M. et al. Septic arthritis and acute rheumatic fever in children: the diagnostic value of serological inflammatory markers. J. Pediatr. Orthop. 35, 318\u2013322 (2015).","journal-title":"J. Pediatr. Orthop."},{"key":"1023_CR19","doi-asserted-by":"publisher","first-page":"e053720","DOI":"10.1136\/bmjopen-2021-053720","volume":"11","author":"AP Ralph","year":"2021","unstructured":"Ralph, A. P. et al. Searching for a technology-driven acute rheumatic fever test: the START study protocol. BMJ Open 11, e053720 (2021).","journal-title":"BMJ Open"},{"key":"1023_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12014-022-09345-1","volume":"19","author":"MT Salie","year":"2022","unstructured":"Salie, M. T. et al. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. Clin. Proteom. 19, 7 (2022).","journal-title":"Clin. Proteom."},{"key":"1023_CR21","doi-asserted-by":"crossref","unstructured":"Deeks, J. J., Bossuyt, P. M., Leeflang, M. M., Takwoingi, Y. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 2 ed (Wiley Blackwell. London, 2022).","DOI":"10.1002\/9781119756194"},{"key":"1023_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","journal-title":"BMJ"},{"key":"1023_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z","volume":"10","author":"ML Rethlefsen","year":"2021","unstructured":"Rethlefsen, M. L. et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst. Rev. 10, 39 (2021).","journal-title":"Syst. Rev."},{"key":"1023_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes, M. D. F. et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: the PRISMA-DTA Statement. JAMA 319, 388\u2013396 (2018).","journal-title":"JAMA"},{"key":"1023_CR25","doi-asserted-by":"publisher","first-page":"n265","DOI":"10.1136\/bmj.n265","volume":"372","author":"JF Cohen","year":"2021","unstructured":"Cohen, J. F. et al. Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration. BMJ 372, n265 (2021).","journal-title":"BMJ"},{"key":"1023_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan, J. et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J. Clin. Epidemiol. 75, 40\u201346 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"1023_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting, P. F. et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155, 529\u2013536 (2011).","journal-title":"Ann. Intern. Med."},{"key":"1023_CR28","unstructured":"GRADEpro G. D. T. GRADEpro GDT: GRADEpro Guideline Development Tool [computer program]: McMaster University and Evidence Prime; [available from: https:\/\/www.gradepro.org\/] (2022)."},{"key":"1023_CR29","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","volume":"336","author":"HJ Schunemann","year":"2008","unstructured":"Schunemann, H. J. et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336, 1106\u20131110 (2008).","journal-title":"BMJ"},{"key":"1023_CR30","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/s11606-012-2021-9","volume":"27","author":"S Singh","year":"2012","unstructured":"Singh, S., Chang, S. M., Matchar, D. B. & Bass, E. B. Chapter 7: grading a body of evidence on diagnostic tests. J. Gen. Intern. Med. 27, S47\u2013S55 (2012).","journal-title":"J. Gen. Intern. Med."},{"key":"1023_CR31","unstructured":"Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 7.2.0. Cochrane Collaboration. [available from: https:\/\/revman.cochrane.org\/] (2024)."},{"key":"1023_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01788-2","volume":"22","author":"MN Plana","year":"2022","unstructured":"Plana, M. N. et al. Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data. BMC Med. Res. Methodol. 22, 306 (2022).","journal-title":"BMC Med. Res. Methodol."},{"key":"1023_CR33","unstructured":"Doebler, P., Sousa-Pinto, B. mada: meta-analysis of diagnostic accuracy. R Package Version 0.11 [avaialble from: https:\/\/cran.r-project.org\/web\/packages\/mada\/index.html] (2022)"},{"key":"1023_CR34","doi-asserted-by":"publisher","first-page":"e050478","DOI":"10.1136\/bmjopen-2021-050478","volume":"12","author":"E Ndagire","year":"2022","unstructured":"Ndagire, E. et al. Modelling study of the ability to diagnose acute rheumatic fever at different levels of the Ugandan healthcare system. BMJ Open 12, e050478 (2022).","journal-title":"BMJ Open"},{"key":"1023_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.113954","volume":"268","author":"S Ali","year":"2024","unstructured":"Ali, S., Beaton, A., Ndagire, E. & Alhag, L. Silent acute rheumatic fever unmasked by using handheld echocardiography for Febrile children presenting in a rheumatic heart disease-endemic area. J. Pediatr. 268, 113954 (2024).","journal-title":"J. Pediatr."},{"key":"1023_CR36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062624","volume":"153","author":"J Pulle","year":"2024","unstructured":"Pulle, J. et al. Specificity of the modified jones criteria. Pediatrics 153, e2023062624 (2024).","journal-title":"Pediatrics"},{"key":"1023_CR37","doi-asserted-by":"publisher","first-page":"e0002064","DOI":"10.1371\/journal.pgph.0002064","volume":"4","author":"L Goddard","year":"2024","unstructured":"Goddard, L., Kaestli, M., Makalic, E. & Ralph, A. P. Outcomes of possible and probable rheumatic fever: a cohort study using northern Australian register data, 2013-2019. PLoS Glob. Public Health 4, e0002064 (2024).","journal-title":"PLoS Glob. Public Health"},{"key":"1023_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.24911\/SJP.106-1652814717","volume":"22","author":"SKM Ali","year":"2022","unstructured":"Ali, S. K. M. Rheumatic heart disease control: the time for a paradigm shift. Sudan J. Paediatr. 22, 125\u2013130 (2022).","journal-title":"Sudan J. Paediatr."},{"key":"1023_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.hlc.2005.08.006","volume":"15","author":"A Ralph","year":"2006","unstructured":"Ralph, A., Jacups, S., McGough, K., McDonald, M. & Currie, B. J. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia\u2019s Northern Territory. Heart Lung Circ. 15, 113\u2013118 (2006).","journal-title":"Heart Lung Circ."},{"key":"1023_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5694\/mja2.50851","volume":"214","author":"AP Ralph","year":"2021","unstructured":"Ralph, A. P. et al. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Med. J. Aust. 214, 220\u2013227 (2021).","journal-title":"Med. J. Aust."},{"key":"1023_CR41","unstructured":"RHDAustralia (ARF\/RHD Writing Group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. (3.2 edition, March 2022) (2020)."},{"key":"1023_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003641","volume":"16","author":"T Machipisa","year":"2023","unstructured":"Machipisa, T. et al. Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study. Circ. Genom. Precis. Med. 16, e003641 (2023).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1023_CR43","first-page":"S1447","volume":"34","author":"E Okello","year":"2024","unstructured":"Okello, E. et al. A plasma protein biomarker for acute rheumatic fever. Cardiol. Young. 34, S1447 (2024).","journal-title":"Cardiol. Young."},{"key":"1023_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-01816-7","volume":"22","author":"E Fisher","year":"2022","unstructured":"Fisher, E., James, C., Mosca, D., Currie, B. J. & Ralph, A. P. Evaluation of an ARF diagnosis calculator: a survey and content analysis. BMC Med. Inf. Decis. Mak. 22, 77 (2022).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"1023_CR45","unstructured":"World Health Organization. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. Geneva: World Health Organization. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240100077 (2024)."},{"key":"1023_CR46","volume":"12","author":"A Spinks","year":"2021","unstructured":"Spinks, A., Glasziou, P. P. & Del Mar, C. B. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst. Rev. 12, CD000023 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1023_CR47","doi-asserted-by":"publisher","first-page":"e0004860","DOI":"10.1371\/journal.pntd.0004860","volume":"10","author":"D Watkins","year":"2016","unstructured":"Watkins, D., Lubinga, S. J., Mayosi, B. & Babigumira, J. B. A cost-effectiveness tool to guide the prioritization of interventions for rheumatic fever and Rheumatic Heart Disease Control in African Nations. PLoS Negl. Trop. Dis. 10, e0004860 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1023_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jpc.15514","volume":"57","author":"J Bennett","year":"2021","unstructured":"Bennett, J. et al. Structured review of primary interventions to reduce group A streptococcal infections, acute rheumatic fever and rheumatic heart disease. J. Paediatr. Child Health 57, 797\u2013802 (2021).","journal-title":"J. Paediatr. Child Health"},{"key":"1023_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons, K. G. et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98, 683\u2013690 (2012).","journal-title":"Heart"},{"key":"1023_CR50","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons, K. G. et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann. Intern. Med. 162, W1\u2013W73 (2015).","journal-title":"Ann. Intern. Med."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01023-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:33:25Z","timestamp":1757381605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01023-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01023-1","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors met the authorship criteria, and their roles and responsibilities were agreed upon prior to the research. Findings were discussed with the WHO development group which assured these were representative of the regional reality in high-prevalence areas of ARF and RHD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Inclusion and ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}